ReviewClinical kidney journal2025
Newer B-cell and plasma-cell targeted treatments for rituximab-resistant patients with membranous nephropathy.
Marc Buse et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this paperpooled itcites it